PT  - JOURNAL ARTICLE
AU  - Faber, Benjamin G.
AU  - Frysz, Monika
AU  - Hartley, April E.
AU  - Ebsim, Raja
AU  - Boer, Cindy G.
AU  - Saunders, Fiona R.
AU  - Gregory, Jennifer S.
AU  - Aspden, Richard M
AU  - Harvey, Nicholas C.
AU  - Southam, Lorraine
AU  - Giles, William
AU  - Maitre, Christine Le
AU  - Wilkinson, J. Mark
AU  - van Meurs, Joyce B.J.
AU  - Zeggini, Eleftheria
AU  - Cootes, Timothy
AU  - Lindner, Claudia
AU  - Kemp, John P.
AU  - Smith, George Davey
AU  - Tobias, Jonathan H.
TI  - Investigation of the genetic architecture of cam morphology, and its relationship with hip osteoarthritis, using alpha angle as a proxy measure
AID  - 10.1101/2022.07.22.22277884
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.22.22277884
4099  - http://medrxiv.org/content/early/2022/07/22/2022.07.22.22277884.short
4100  - http://medrxiv.org/content/early/2022/07/22/2022.07.22.22277884.full
AB  - Objectives To examine the genetic architecture of cam morphology, using alpha angle (AA) as a proxy measure, we conducted an AA genome wide association study (GWAS), followed by Mendelian randomisation (MR) to evaluate its causal relationship with hip osteoarthritis (HOA).Methods Observational analyses examined associations between AA derived from hip DXA scans in UK Biobank (UKB), and radiographic HOA (rHOA) and subsequent total hip replacement (THR). Afterwards, an AA GWAS meta-analysis was performed (n=44,214), using AA previously derived in the Rotterdam Study (RS). Linkage disequilibrium score regression assessed the genetic correlation between AA and HOA. Genetic associations with P<5×10−8 instrumented AA for two-sample MR.Results DXA-derived AA showed expected associations between AA and rHOA (OR 1.63 [95% CI 1.58-1.67]) and THR (HR 1.45 [1.33-1.59]) in UKB. The heritability of AA was 10% and AA had a moderate genetic correlation with HOA (rg=0.26 [0.10-0.43]). Eight independent genetic signals were associated with AA. Two-sample MR provided weak evidence of causal effects of AA on HOA risk (inverse variance weighted (IVW): OR=1.84 [1.14-2.96], P 0.01). In contrast, genetic predisposition for HOA had stronger evidence of a causal effect on increased AA (IVW: β=0.09 [0.04-0.13], P 4.58 × 10−05).Conclusions Expected observational associations between AA and related clinical outcomes provided face-validity for the DXA-derived AA measures. Evidence of bidirectional associations between AA and HOA, particularly in the reverse direction, suggest that hip shape remodelling secondary to a genetic predisposition to HOA contribute to the well-established relationship between HOA and cam morphology in older adults.Competing Interest StatementCL has a patent for a image processing apparatus and method for fitting a deformable shape model to an image using random forest regression voting. This is licensed with royalties to Optasia Medical. NH reports consultancy fees and honoraria from UCB and Kyowa Kirin. CLM reports consultancy fees and patent royalties from Flexion Therapeutics.Funding StatementBGF is supported by a Medical Research Council (MRC) clinical research training fellowship (MR/S021280/1). RE, MF, FS are supported, and this work is funded by a Wellcome Trust collaborative award (reference number 209233). CL is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (223267/Z/21/Z). This research was funded in whole, or in part, by the Wellcome Trust [Grant numbers 080280/Z/06/Z, 20378/Z/16/Z, 223267/Z/21/Z]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. NCH acknowledges support from the MRC and NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton. BGF, MF, AEH, GDS, JHT work in the MRC Integrative Epidemiology Unit at the University of Bristol, which is supported by the MRC (MC_UU_00011/1). JPK is funded by a National Health and Medical Research Council (Australia) Investigator grant (GNT1177938).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Information Governance Board for Health and Social Care and Northwest Multi-Centre Research Ethics Committee (11/NW/0382) and UK Biobank Ethics Advisory committee gave ethical approval for all work in this study undertaken with UK Biobank data (UK Biobank application number 17295). The South Yorkshire and North Derbyshire Musculoskeletal Biobank (REC reference: 20/SC/0144) ethics committee gave ethical approval for the immunohistochemistry experiments in this study. The Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG) gave ethical approval for all work undertaken with data from the Rotterdam Study included in this study. The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; www.trialregister.nl) and into the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/) under shared catalogue number NTR6831. All participants provided informed consent for this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe alpha angle GWAS meta-analysis summary statistics are to be uploaded to the GWAS catalogue (https://www.ebi.ac.uk/gwas/). The individual level data from this study will be available from UK Biobank in a forthcoming data release. Users must be registered with UK Biobank to access their resources (https://bbams.ndph.ox.ac.uk/ams/). https://www.ebi.ac.uk/gwas/ https://bbams.ndph.ox.ac.uk/ams/